Evidence map›Paper›PMID 28319464›Full record

ReviewJournal of leukocyte biology2017

The Dr. Jekyll and Mr. Hyde complexity of the macrophage response in disease.

Danielle Y F Twum, Lauren Burkard-Mandel, Scott I Abrams

Abstract readReview
In one paragraph

Review in Journal of leukocyte biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Danielle Y F TwumDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA.
Lauren Burkard-MandelDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA.
Scott I AbramsDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA scott.abrams@roswellpark.org.

Funding

MULTIDISCIPLINARY APPROACHES TUMOR IMMUNOLOGYT32CA085183 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Scott I. Abrams · 2001 to 2026
$3.1M
Mechanisms Underlying Functional Programs of Tumor-Associated MacrophagesR01CA172105 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI ABRAMS, SCOTT I. · 2015 to 2019
$2.0M
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and FunctionR01CA140622 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI ABRAMS, SCOTT I. · 2011 to 2015
$2.0M
Mechanisms of Macrophage-Mediated Tumor MetastasisF30CA200133 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BURKARD, LAUREN E · 2015 to 2018
$135k
NCI NIH HHS F30 CA200133NCI NIH HHS R01 CA140622NCI NIH HHS R01 CA172105NCI NIH HHS T32 CA085183
6 · The paper itself

Abstract

Macrophages comprise a highly diverse cell population expressing a continuum of biologic activities dictated by exposure to a plethora of inflammatory cues. Moreover, in contrast to most other hematopoietic populations, macrophages can arise from multiple sites-namely, the bone marrow or yolk sac, adding to the complexity of macrophage biology during health and disease. Nonetheless, it is this very type of diversity that is indispensable for macrophages to respond effectively to pathologic insults. Most of the interest in macrophage biology has been devoted to bone marrow-derived populations, but it is now becoming clearer that tissue-resident populations, which arise from distinct hematopoietic compartments, serve critical roles in host defense, including protection against neoplastic disease. Depending on the inflammatory milieu, macrophages can behave as a "two-edged sword," playing either host-protective (i.e., antitumor) or host-destructive (i.e., protumor) roles. Accordingly, we review herein the mechanisms that instruct macrophage functional diversity within their microenvironments, with special emphasis on transcriptional regulation, which is less understood. Given their polarizing positions in disease processes, we will also provide an overview of strategies that target macrophages or their effector mechanisms for therapeutic purposes.

Indexed as

AnimalsHumansImmunity, InnateMacrophagescancerimmunotherapymacrophagestranscriptional regulation

Identifiers

PMID28319464
PMCPMC5505749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.